查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966053

全球靜脈曲張治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Varicose Veins Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 167 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計靜脈曲張治療市場將從 2025 年的 15.7 億美元成長到 2034 年的 34.4 億美元，2026 年至 2034 年的複合年成長率為 9.1%。

由於靜脈疾病發病率的上升以及人們對微創治療日益成長的興趣，全球靜脈曲張治療市場正經歷著穩定成長。治療方法包括硬化療法、經靜脈雷射療法和射頻消融術。人口老化和久坐的生活方式是推動這項需求成長的重要因素。

主要成長要素包括非手術治療技術的進步、診斷技術的改進以及醫療保健服務的普及。人們對美容手術日益成長的認知也推動了市場擴張。恢復期較短的門診治療越來越受歡迎。

由於雷射和導管技術的持續創新，前景依然樂觀。新興市場醫療基礎設施的不斷完善提供了成長機會。更重視早期診斷和病患教育將進一步加速市場發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球靜脈曲張治療市場：依產品分類

  • 市場分析、洞察與預測
  • 消融設備（射頻消融/熱消融、雷射消熔設備、超音波消融設備）
  • 導管/硬化療法和沾黏注射套裝
  • 壓縮裝置和服裝
  • 其他

第5章：全球靜脈曲張治療市場：依治療類型分類

  • 市場分析、洞察與預測
  • 靜脈消融療法
  • 硬化療法/沾黏注射
  • 結紮和剝離
  • 輔助治療

第6章：全球靜脈曲張治療市場：依疾病類型分類

  • 市場分析、洞察與預測
  • 大隱靜脈曲張
  • 小隱靜脈曲張
  • 其他

第7章 全球靜脈曲張治療市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院及門診手術中心
  • 專科診所
  • 其他

第8章 全球靜脈曲張治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • AngioDynamicsInc
    • Boston Scientific Corporation（BTG International Inc.）
    • DJO, LLC（Enovis Corporation）
    • Essity Aktiebolag（Publ）（BSN Medical）
    • F Care Systems NV
    • Medtronic Plc
    • Miravas（IPSA Group）
    • Mylan NV（Viatris, Inc.）
    • SIGVARIS Group
    • Teleflex Incorporated
    • VVT Medical
    • Wontech Co.Ltd
簡介目錄
Product Code: VMR11210210

The Varicose Veins Treatment Market size is expected to reach USD 3.44 Billion in 2034 from USD 1.57 Billion (2025) growing at a CAGR of 9.1% during 2026-2034.

The Global Varicose Veins Treatment Market has witnessed steady growth due to increasing prevalence of venous disorders and rising awareness of minimally invasive procedures. Treatments include sclerotherapy, endovenous laser therapy, and radiofrequency ablation. Aging populations and sedentary lifestyles have significantly contributed to demand.

Major growth drivers include technological advancements in non-surgical treatments, improved diagnostic techniques, and expanding healthcare access. Growing cosmetic awareness also supports market expansion. Outpatient procedures with shorter recovery times are gaining popularity.

Future prospects remain positive as innovation in laser and catheter-based technologies continues. Emerging markets with improving healthcare infrastructure will offer growth opportunities. Increasing focus on early diagnosis and patient education will further drive market development.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Ablation Devices (Radiofrequency Ablation / Thermal Ablation, Laser Ablation Devices, Ultrasound Ablation Devices)
  • Catheters / Kits for Sclerotherapy & Adhesion Injection
  • Compression Devices / Garments
  • Others

By Treatment Type

  • Endovenous Ablation
  • Sclerotherapy/Adhesion Injection
  • Ligation/Stripping
  • Supportive Treatment

By Disease Type

  • Greater Saphenous Varicose Veins
  • Small Saphenous Varicose Veins
  • Others

By End-user

  • Hospitals & Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

COMPANIES PROFILED

  • AngioDynamics, Inc, Boston Scientific Corporation BTG International Inc, DJO, LLC Enovis Corporation, Essity Aktiebolag publ BSN Medical, F Care Systems NV, Medtronic plc, Miravas IPSA Group, Mylan NV Viatris, Inc, SIGVARIS Group, Teleflex Incorporated, VVT Medical, Wontech Co, Ltd

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Ablation Devices (Radiofrequency Ablation / Thermal Ablation, Laser Ablation Devices, Ultrasound Ablation Devices) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Catheters / Kits for Sclerotherapy & Adhesion Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Compression Devices / Garments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment Type
  • 5.2. Endovenous Ablation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Sclerotherapy/Adhesion Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Ligation/Stripping Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Supportive Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY DISEASE TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Disease Type
  • 6.2. Greater Saphenous Varicose Veins Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Small Saphenous Varicose Veins Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals & Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VARICOSE VEINS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Treatment Type
    • 8.2.3 By Disease Type
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Treatment Type
    • 8.3.3 By Disease Type
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Treatment Type
    • 8.4.3 By Disease Type
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Treatment Type
    • 8.5.3 By Disease Type
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Treatment Type
    • 8.6.3 By Disease Type
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL VARICOSE VEINS TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 AngioDynamicsInc
    • 10.2.2 Boston Scientific Corporation (BTG International Inc.)
    • 10.2.3 DJO, LLC (Enovis Corporation)
    • 10.2.4 Essity Aktiebolag (Publ) (BSN Medical)
    • 10.2.5 F Care Systems NV
    • 10.2.6 Medtronic Plc
    • 10.2.7 Miravas (IPSA Group)
    • 10.2.8 Mylan N.V. (Viatris, Inc.)
    • 10.2.9 SIGVARIS Group
    • 10.2.10 Teleflex Incorporated
    • 10.2.11 VVT Medical
    • 10.2.12 Wontech Co.Ltd